… This review focuses on the role of angiopoietins in the pathophysiology of sepsis and ALI/ARDS.
All original experimental and patient studies on angiopoietins and sepsis/endotoxemia, …

… the body more susceptible to pathogenic infection (29). Hence, clear diagnosis and
effective treatment during the early phase of sepsis will significantly improve clinical outcomes. …

… an overview of sepsis immune pathophysiology, to update the choice of therapeutic approaches
targeting different immunological mechanisms in the course of sepsis and septic shock, …

… in sepsis may significantly impair B and T cell function (18). Therefore, inhibition of apoptosis
has served as a therapeutic target for sepsis. … experiments provide potential therapies that …

… been laid on identifying novel therapeutic targets and prognostic biomarkers for sepsis …
of sepsis, and confirms CHs’ potential as therapeutic targets in future sepsis management. …

… sepsis models. In this review, we present the main results of studies on therapeutic agents in
targeting HSPs in sepsis treatment. We … As a therapeutic targets, HSPs have aroused great …

… effectively highlighted potential therapeutic targets, BPs and pharmacological pathways of
VC action against sepsis. The bioinformatics data presented identify potential targets that may …

… To date, treatment for sepsis consists of eradication of infection through early and … presents
those drug targets that are currently under active investigation for the treatment of sepsis. …

… Consequently, the inhibition of ER stress has been recognized as a viable therapeutic
target for sepsis with the demonstrated ability to attenuate apoptosis as well as inflammation in …

… pathogenetic differences of sepsis in the elderly that can increase its incidence and mortality,
with emphasis on the immunologic changes, clinical impact and possible new therapeutic …